Literature DB >> 9600920

Identification of an additional negative regulatory region for p53 sequence-specific DNA binding.

B F Müller-Tiemann1, T D Halazonetis, J J Elting.   

Abstract

The DNA binding activity of p53 is crucial for its tumor suppressor function and is subject to tight regulation. Previous studies revealed that the inhibitory function of the p53 C terminus is implicated in the latent, low affinity sequence-specific DNA binding activity of p53 in the uninduced state. Sequence-specific DNA binding of p53 has been shown to be activated by several posttranslational modifications and interacting proteins that target predominantly the C terminus. Moreover, several authors have shown that synthetic peptides corresponding to p53 C-terminal sequences activate p53 sequence-specific DNA binding. In an effort to identify the interaction site of p53 with these activating peptides we assessed complex formation between p53 deletion constructs and C-terminal activating peptides by peptide affinity precipitation. This study revealed that two distal regions of the p53 molecule contribute synergistically to the interaction with activating C-terminal peptides: amino acids 80-93 and 364-393. The C-terminal residues 364-393 are already well characterized as having negative regulatory function. DNA binding analyses with these deletion constructs reveal a comparable negative regulatory activity for residues 80-93, defining this region as a previously unidentified negative regulatory domain of p53. Furthermore, synthetic peptides spanning this newly identified proline-rich negative regulatory region (residues 80-93) are able to activate p53 sequence-specific DNA binding in vitro. We suggest that both negative regulatory regions, residues 80-93 and 364-393, contribute cooperatively to the maintenance of the latent, low-affinity DNA binding conformation of p53.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9600920      PMCID: PMC27588          DOI: 10.1073/pnas.95.11.6079

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  47 in total

1.  Activation of p53 sequence-specific DNA binding by short single strands of DNA requires the p53 C-terminus.

Authors:  J Jayaraman; C Prives
Journal:  Cell       Date:  1995-06-30       Impact factor: 41.582

2.  WAF1, a potential mediator of p53 tumor suppression.

Authors:  W S el-Deiry; T Tokino; V E Velculescu; D B Levy; R Parsons; J M Trent; D Lin; W E Mercer; K W Kinzler; B Vogelstein
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

3.  Activation of the cryptic DNA binding function of mutant forms of p53.

Authors:  T R Hupp; D W Meek; C A Midgley; D P Lane
Journal:  Nucleic Acids Res       Date:  1993-07-11       Impact factor: 16.971

4.  p53 domains: identification and characterization of two autonomous DNA-binding regions.

Authors:  Y Wang; M Reed; P Wang; J E Stenger; G Mayr; M E Anderson; J F Schwedes; P Tegtmeyer
Journal:  Genes Dev       Date:  1993-12       Impact factor: 11.361

5.  A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein.

Authors:  J Bargonetti; J J Manfredi; X Chen; D R Marshak; C Prives
Journal:  Genes Dev       Date:  1993-12       Impact factor: 11.361

6.  High-resolution structure of the oligomerization domain of p53 by multidimensional NMR.

Authors:  G M Clore; J G Omichinski; K Sakaguchi; N Zambrano; H Sakamoto; E Appella; A M Gronenborn
Journal:  Science       Date:  1994-07-15       Impact factor: 47.728

7.  The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots.

Authors:  N P Pavletich; K A Chambers; C O Pabo
Journal:  Genes Dev       Date:  1993-12       Impact factor: 11.361

8.  Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations.

Authors:  Y Cho; S Gorina; P D Jeffrey; N P Pavletich
Journal:  Science       Date:  1994-07-15       Impact factor: 47.728

9.  WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis.

Authors:  W S el-Deiry; J W Harper; P M O'Connor; V E Velculescu; C E Canman; J Jackman; J A Pietenpol; M Burrell; D E Hill; Y Wang
Journal:  Cancer Res       Date:  1994-03-01       Impact factor: 12.701

10.  Conformational shifts propagate from the oligomerization domain of p53 to its tetrameric DNA binding domain and restore DNA binding to select p53 mutants.

Authors:  T D Halazonetis; A N Kandil
Journal:  EMBO J       Date:  1993-12-15       Impact factor: 11.598

View more
  23 in total

1.  The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription.

Authors:  J S Steffan; A Kazantsev; O Spasic-Boskovic; M Greenwald; Y Z Zhu; H Gohler; E E Wanker; G P Bates; D E Housman; L M Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

2.  A peptide that binds and stabilizes p53 core domain: chaperone strategy for rescue of oncogenic mutants.

Authors:  Assaf Friedler; Lars O Hansson; Dmitry B Veprintsev; Stefan M V Freund; Thomas M Rippin; Penka V Nikolova; Mark R Proctor; Stefan Rüdiger; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-08       Impact factor: 11.205

3.  Peptides from the amino terminal mdm-2-binding domain of p53, designed from conformational analysis, are selectively cytotoxic to transformed cells.

Authors:  M Kanovsky; A Raffo; L Drew; R Rosal; T Do; F K Friedman; P Rubinstein; J Visser; R Robinson; P W Brandt-Rauf; J Michl; R L Fine; M R Pincus
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

4.  Negative regulation-resistant p53 variant enhances oncolytic adenoviral gene therapy.

Authors:  Taeyoung Koo; Il-Kyu Choi; Minjung Kim; Jung-Sun Lee; Eonju Oh; Jungho Kim; Chae-Ok Yun
Journal:  Hum Gene Ther       Date:  2012-02-21       Impact factor: 5.695

5.  Comparison of the protein-protein interfaces in the p53-DNA crystal structures: towards elucidation of the biological interface.

Authors:  Buyong Ma; Yongping Pan; K Gunasekaran; R Babu Venkataraghavan; Arnold J Levine; Ruth Nussinov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-28       Impact factor: 11.205

6.  The structure of p53 tumour suppressor protein reveals the basis for its functional plasticity.

Authors:  Andrei L Okorokov; Michael B Sherman; Celia Plisson; Vera Grinkevich; Kristmundur Sigmundsson; Galina Selivanova; Jo Milner; Elena V Orlova
Journal:  EMBO J       Date:  2006-10-19       Impact factor: 11.598

7.  Multiple conformations of full-length p53 detected with single-molecule fluorescence resonance energy transfer.

Authors:  Fang Huang; Sridharan Rajagopalan; Giovanni Settanni; Richard J Marsh; Daven A Armoogum; Nick Nicolaou; Angus J Bain; Eitan Lerner; Elisha Haas; Liming Ying; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-20       Impact factor: 11.205

8.  p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage.

Authors:  L Liu; D M Scolnick; R C Trievel; H B Zhang; R Marmorstein; T D Halazonetis; S L Berger
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

9.  Structure and promoter characterization of aldo-keto reductase family 1 B10 gene.

Authors:  Ziwen Liu; Linlin Zhong; Paulette A Krishack; Sarah Robbins; Julia X Cao; Yupei Zhao; Stephen Chung; Deliang Cao
Journal:  Gene       Date:  2009-02-21       Impact factor: 3.688

10.  p53 Amino-terminus region (1-125) stabilizes and restores heat denatured p53 wild phenotype.

Authors:  Anuj Kumar Sharma; Amjad Ali; Rajan Gogna; Amir Kumar Singh; Uttam Pati
Journal:  PLoS One       Date:  2009-10-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.